Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
07/2010
07/15/2010US20100178344 Extended-Release Composition Comprising a Somatostatin Derivative in Microparticles
07/15/2010US20100178341 BILAYERED TABLET COMPRISING NIACIN AND HMG-CoA REDUCTASE INHIBITOR
07/15/2010US20100178337 Composition comprising an active agent with low aqueous solubility
07/15/2010US20100178281 Supplemention of maternal diet
07/15/2010CA2749180A1 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases
07/15/2010CA2748827A1 Composition and method for treatment of diabetes
07/15/2010CA2747720A1 Yl-based insulin-like growth factors exhibiting high activity at the insulin receptor
07/15/2010CA2747490A1 Insulin analogs
07/15/2010CA2746746A1 Arylcyclopropylacetamide derivatives useful as glucokinase activators
07/15/2010CA2745039A1 Treatment of diabetes in patients with inadequate glycemic control despite metformin therapy comprising a dpp-iv inhibitor
07/15/2010CA2744558A1 Amide-based insulin prodrugs
07/14/2010EP2206772A2 Method of collecting placental stem cells
07/14/2010EP2206721A1 Neuromedin u derivative
07/14/2010EP2206720A1 Albumin fusion proteins
07/14/2010EP2206511A1 Protein a compositions and methods of use
07/14/2010EP2206510A1 Therapeutic agent for diabetes
07/14/2010EP2206509A1 Aloe vera extract, method of producing aloe vera extract, and hyperglycemia improving agent
07/14/2010EP2206497A1 Polymorphic form of atorvastatin calcium
07/14/2010EP2205639A2 Anti-pcsk9 and methods for treating lipid and cholesterol disorders
07/14/2010EP2205601A1 Purine derivatives as adenosine al receptor ligands
07/14/2010EP2205598A1 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
07/14/2010EP2205595A1 Oxadiazole- and oxazole-substituted benzimidazole- and indole-derivatives as dgat1 inhibitors
07/14/2010EP2205588A2 Oxypiperidine derivatives as histamine receptor antagonists
07/14/2010EP2205576A1 Benzothiazoles as ghrelin receptor modulators
07/14/2010EP2205562A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
07/14/2010EP2205548A1 Substituted biphenyl gpr40 modulators
07/14/2010EP2205317A1 Pyridine derivatives for the treatment of amyloid-related diseases
07/14/2010EP2205265A1 Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agent
07/14/2010EP2205243A2 Mast cell stabilizers in the treatment of obesity
07/14/2010EP2205216A1 Composition for controlling lipase catalyzed reactions
07/14/2010EP1951659B1 Glucagon receptor antagonists, preparation and therapeutic uses
07/14/2010EP1863812B1 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
07/14/2010EP1784188B1 Fused triazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
07/14/2010EP1648443B1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands
07/14/2010CN201524271U Lovastatin-nicotinic acid double-release capsule
07/14/2010CN201524269U Combined capsule loaded with replaglinide solid preparation and metformin solid preparation
07/14/2010CN1955179B [1,4]diazepino[6,7,1-IJ]quinoline derivatives as antipsychotic and antiobesity agents
07/14/2010CN1859916B Drugs, foods and drinks for ameliorating hyperglycemia
07/14/2010CN101778831A Novel piperazine amide derivatives
07/14/2010CN101778633A Weekly administration of dipeptidyl peptidase inhibitors
07/14/2010CN101775416A Novel method for preparing orlistat
07/14/2010CN101775349A Health-care vinegar, brewing method and hyperglycemic reduction application thereof
07/14/2010CN101775348A Health-care vinegar, brewing method and application in preventing cardiovascular diseases thereof
07/14/2010CN101775061A Ilex latifolia thunb saponin compound
07/14/2010CN101775053A Method for extracting amino acid and nucleic acid from shell, hoofs and horns of animal
07/14/2010CN101775026A Spiro alkaloid compound, medicinal composition comprising same and preparation method and application thereof
07/14/2010CN101775020A Poly-substituted chromone pyrrole compound and synthetic method and application thereof
07/14/2010CN101775008A Antidiabetic compound, preparation method and application thereof
07/14/2010CN101775000A Process fot the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof
07/14/2010CN101773624A Traditional Chinese medicine composition for curing diabetes and preparation method thereof
07/14/2010CN101773605A Herbal wasting-thirst penetrant for treating diabetes
07/14/2010CN101773604A Sugar reducing medicinal pillow for diabetes
07/14/2010CN101773572A Chinese-western medicine composition containing nateglinide
07/14/2010CN101773525A Solid oral agent preparation containing rogridone rosiglitazone and monascusred rice
07/14/2010CN101773523A Traditional Chinese medicine antimanic drug for treatment of hyperlipemia and preparation thereof
07/14/2010CN101773517A H2S or H2S donator temperature sensitivity instant gel preparation for injection
07/14/2010CN101773514A Organic manganese-supplementing agent and preparation method and application thereof
07/14/2010CN101773506A Composition of cefpiramide and sodium glycinate or special solvent composition containing sodium glycinate
07/14/2010CN101773494A New application of green tea polyphenol
07/14/2010CN101773486A Clinofibrate medicine composition
07/14/2010CN101773473A Preparation method of supercritical antisolvent of nano-insulin powder
07/14/2010CN101773465A Polymer micelle medicine carrying system using amino acid as stabilizing agent
07/14/2010CN101773463A Selenium-enriched nano pearl powder formula and production method thereof
07/14/2010CN101297791B Alprostadil composition and preparation thereof
07/14/2010CN101210009B Bruguiesulfurol, derivatives and preparation method thereof, and application for the same in preparing diabetes treatment medicament
07/14/2010CN101103757B Buckwheat flower tea and its preparing process
07/14/2010CN101077881B 1-O-beta-D-glucopyranosylgeraniol-10,5-olide and use thereof
07/14/2010CN101007992B Health white spirit containing beneficial functional component
07/13/2010US7756643 Method for determining the biological effect and/or activity of at least one drug, chemical substances and/or pharmaceutical composition based on their effect on the methylation status of DNA
07/13/2010US7754890 Arylsulfones and uses related thereto
07/13/2010US7754876 Method for purification of lactose
07/13/2010US7754856 Human sodium-dependent bile acid transporter proteins
07/13/2010US7754772 (2R)-2,3-bis(nitrooxy)propyl(2S)-2(6-methoxy(2-naphthyl)propanoate, used for treating inflammation, pain and fever; gastrointestinal disorders; wound healing agents; preventing gastrointestinal, renal and/or respiratory toxicities; side effect reduction
07/13/2010US7754757 Dipeptidylpeptidase IV (DPP-IV) inhibitory activity; (2S,4S)-1-[[N-(4-ethoxycarbonylbicyclo[2.2.2]oct-1-yl)amino]acetyl]-4-fluoropyrrolidine-2-carbonitrile)); diabetes
07/13/2010US7754748 Method for treating obesity
07/13/2010US7754743 Heteroarylcarbamoylbenzene derivatives
07/13/2010US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
07/13/2010US7754711 Pyridazine derivatives and their use as therapeutic agents
07/13/2010US7754704 administering 4-methylcholest-7-en-3-ol, 4-methylergost-7-en-3-ol, and 4-methylstigmast-7-en-3-ol; lowering hemoglobin A1c
07/13/2010US7754701 toothpastes, mouthwashes, chewing gums, tableted candy, for inhibiting induction of dental caries
07/13/2010US7754255 Bone metabolism improving agent
07/13/2010US7754205 Composition for transmucosal administration containing conenzyme Q as the active ingredient
07/13/2010US7754204 Probiotic yeast broth for reducing blood or hepatic cholesterol level and preventing and/or treating cell proliferative and atherogenic disorders
07/13/2010CA2534006C Use of angiotensin ii receptor antagonists
07/13/2010CA2505910C Imidazoquinoline derivatives as adenosine a3 receptor ligands
07/13/2010CA2457451C Naphthyridine derivatives
07/13/2010CA2446820C Novel pyrrole derivatives as pharmaceutical agents
07/13/2010CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
07/13/2010CA2443135C Pharmaceutically active compounds and methods of use
07/13/2010CA2441701C Detection of il4 and il13 polymorphisms in determination of type 1 diabetes susceptibility
07/13/2010CA2440979C Spirolaximes for use in the treatment of pathologies that respond to ppar-.gamma. receptor activation
07/13/2010CA2432145C Glucopyranosyloxypyrazole derivatives and use thereof in medicines
07/13/2010CA2430539C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
07/13/2010CA2409697C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/13/2010CA2388754C Therapeutic intervention to mimic the effect of caloric restriction
07/08/2010WO2010078373A1 Substituted diketopiperazine analogs for use as drug delivery agents
07/08/2010WO2010078324A2 Companion animal compositions including lipoic acid and methods of use thereof
07/08/2010WO2010078307A1 Spiro-oxindole-derivatives as sodium channel blockers
07/08/2010WO2010078301A1 Compositions and methods for treating and preventing weight-related disorders in companion animals
07/08/2010WO2010078103A1 Modulators of cystic fibrosis transmembrane conductance regulator
1 ... 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 ... 1298